BioCentury
ARTICLE | Financial News

Mersana raises $35M, names Protopapas CEO

March 3, 2015 1:42 AM UTC

Mersana Therapeutics Inc. (Cambridge, Mass.) raised $35 million in a series B-1 round led by existing investor New Enterprise Associates and named Anna Protopapas president and CEO.

New investors Rock Springs Capital and Elliott Sigal, a venture partner at NEA and former EVP at Bristol-Myers Squibb Co. (NYSE:BMY), also participated, as did existing investors Pfizer Venture Investments and Fidelity Biosciences. ...